secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phreesia, Inc. (PHR)
CIK:        0001412408
Form:       8-K
Filed at:   2021-12-08T23:59:59+00:00
Accession:  0001412408-21-000090
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phreesia Q3 revenue $55.9M (+45% YoY); FY22 outlook raised to $211M
-------------------------------------------------------------------

- Revenue $55.9M, up 45% YoY; net loss $36.3M ($0.71/share) vs $6.7M loss prior year.
- Adjusted EBITDA -$17.6M vs +$1.2M a year ago, reflecting increased growth investment.
- FY2022 revenue outlook raised to $211M from $195-198M; FY2023 growth guided 20-25%.
- Cash $400.4M after follow-on offering generating $245.8M net proceeds.
- Agreed to acquire Insignia Health for $35M cash; adds Patient Activation Measure (PAM).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412408/000141240821000090/0001412408-21-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412408/000141240821000090/phr-20211208.htm
  HTML page:      https://secwatch.observer/filing/0001412408-21-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer